piracetam has been researched along with Gaucher Disease in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Gaucher Disease: An autosomal recessive disorder caused by a deficiency of acid beta-glucosidase (GLUCOSYLCERAMIDASE) leading to intralysosomal accumulation of glycosylceramide mainly in cells of the MONONUCLEAR PHAGOCYTE SYSTEM. The characteristic Gaucher cells, glycosphingolipid-filled HISTIOCYTES, displace normal cells in BONE MARROW and visceral organs causing skeletal deterioration, hepatosplenomegaly, and organ dysfunction. There are several subtypes based on the presence and severity of neurological involvement.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present the first reported case of a rapid clinical and electroencephalographic response to intravenous levetiracetam infusion of myoclonic status epilepticus in a patient with progressive myoclonus epilepsy due to Gaucher disease." | 7.78 | Gaucher disease: successful treatment of myoclonic status epilepticus with levetiracetam. ( Knight, EM; Lenz, T; Tuxhorn, I; Vaca, GF, 2012) |
| "We present the first reported case of a rapid clinical and electroencephalographic response to intravenous levetiracetam infusion of myoclonic status epilepticus in a patient with progressive myoclonus epilepsy due to Gaucher disease." | 3.78 | Gaucher disease: successful treatment of myoclonic status epilepticus with levetiracetam. ( Knight, EM; Lenz, T; Tuxhorn, I; Vaca, GF, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vaca, GF | 1 |
| Lenz, T | 1 |
| Knight, EM | 1 |
| Tuxhorn, I | 1 |
1 other study available for piracetam and Gaucher Disease
| Article | Year |
|---|---|
Gaucher disease: successful treatment of myoclonic status epilepticus with levetiracetam.
Topics: Adolescent; Anticonvulsants; Electroencephalography; Epilepsies, Myoclonic; Gaucher Disease; Humans; | 2012 |